A detailed history of Sterling Investment Counsel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sterling Investment Counsel, LLC holds 8,322 shares of ABBV stock, worth $1.49 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
8,322
Previous 7,235 15.02%
Holding current value
$1.49 Million
Previous $1.24 Million 32.5%
% of portfolio
0.59%
Previous 0.49%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $178,094 - $216,671
1,087 Added 15.02%
8,322 $1.64 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $68,571 - $80,076
443 Added 6.52%
7,235 $1.24 Million
Q1 2024

Apr 26, 2024

BUY
$159.82 - $182.1 $78,311 - $89,229
490 Added 7.78%
6,792 $1.24 Million
Q4 2023

Jan 12, 2024

BUY
$137.6 - $154.97 $197,593 - $222,536
1,436 Added 29.51%
6,302 $976,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $118,895 - $137,638
890 Added 22.38%
4,866 $725,000
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $36,970 - $46,007
-279 Reduced 6.56%
3,976 $535,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $216,770 - $249,643
1,499 Added 54.39%
4,255 $678,000
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $14,245 - $17,084
103 Added 3.88%
2,756 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $51,939 - $59,570
387 Added 17.08%
2,653 $356,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $82,847 - $105,325
602 Added 36.18%
2,266 $347,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $24,680 - $30,621
187 Added 12.66%
1,664 $270,000
Q4 2021

Apr 29, 2022

BUY
$107.43 - $135.93 $158,674 - $200,768
1,477 New
1,477 $200,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sterling Investment Counsel, LLC Portfolio

Follow Sterling Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Counsel, LLC with notifications on news.